期刊文献+

中美疫苗不良事件监测体系比较 被引量:8

下载PDF
导出
摘要 疫苗在人类与疾病的抗争史中扮演着举足轻重的角色,接种疫苗已成为世界公认的最经济、最方便、最有效的预防和控制传染病的手段。疫苗作为一种药品,并不是绝对安全的。尽管它带来的效益远远高于风险,但也可能产生有损于机体的不良反应。因疫苗的接种对象是健康人群,特别是儿童占较大比重,因此对疫苗安全性的要求通常高于一般药品,公众承担风险的能力也较弱。
作者 董铎 孙利华
出处 《药物流行病学杂志》 CAS 2007年第5期310-313,共4页 Chinese Journal of Pharmacoepidemiology
  • 相关文献

参考文献12

  • 1朱蓉,徐葛林.全球疫苗安全性展望[J].国外医学(预防.诊断.治疗用生物制品分册),2005,28(4):165-167. 被引量:3
  • 2WHO. Global status of immunization safety:a report based on the WHO/UNICEF Joint Reporting Form, 2003 update [J]. Weekly epidemiological record,2005,80(16) :141-148
  • 3WHO. Global status of immunization safety:a report based on the WHO/UNICEF Joint Reporting Form, 2004 update [ J ]. Weekly epidemiological record, 2005, 80(42) :361-368
  • 4VAERS Continuing Education. Vaccine Safety Post-marketing Surveillance: The Vaccine Adverse Event Reporting System[ EB/OL]. http://www. vaers. hss. gov/ce. htm. 2002/ 2007-05-01
  • 5Rosenthal S, Chen R. the Reporting Sensitivities of Two Passive Surveillance Systems for Vaccine Adverse Events [ J ]. American Journal of Public Health, 1995,85 : 1706- 1709
  • 6Federal Regulations. 21 CFR, section 600.80. Postmarketing reporting of adverse experiences [ S/OL ]. http ://www. accessdata. fda. gov/scripts/cdrh/cfdocs/cfcfr/ CFRSearch. cfm? fr = 600. 80. 2006/2007-05-01
  • 7唐慧鑫,孙骏,马爱霞.从美国疫苗伤害救济制度探讨对建立我国预防接种异常反应救济机制的启示[J].中国药物警戒,2007,4(3):132-136. 被引量:15
  • 8Casiday RE, Cox AR. Restoring Confidence in Vaccine by Explaining Vaccine Safety Monitoring [ J ]. Drug Safety, 2006,29 ( 12 ) : 1105-1109
  • 9Accessing VAERS Public Data [ DB/OL]. http://vaers. hhs. gov/scripts/data.cfm #downloading. 2007/2007-05-01
  • 10张苏琳,王越,孙骏,徐厚明.中美预防接种不良事件监测系统比较[J].药物流行病学杂志,2005,14(5):309-313. 被引量:16

二级参考文献17

  • 1疫苗的供应与质量──免疫接种后不良反应监测──[J].疾病监测,1996,11(12):472-473. 被引量:3
  • 2[1]卫生部.预防接种工作规范[S].2005.
  • 3[3]Vaccine Injury Compensation Trust Fund[S/OL].[2006-12-15].http://www.washingtonwatchdog.org/documents/usc/ttl26/subttlI/ch98/subchA/sec9510.html.
  • 4[4]INTERNAL REVENUE CODE-SubtitleD Miscellaneous Excis Taxes-CHAPTER32 Manufacturers Excise Taxes-Subchapter C Certain Vaccines[S/OL].[2006-12-15].http://www.washingtonwatchdog.org/ documents/usc/ttl26/subttlD/ch32/subchC/sec4131.html.
  • 5[5]Vaccine Injury Table[EB/OL].[2006-12-15].http://www.hrsa.gov/vaccinecompensation/table.htm.
  • 6[6]National Vaccine Injury Compensation Program Sec.300aa-16.Limitations of actions[S/OL].[2006-12-15].http://www.washingtonwatchdog.org/documents/usc/ttl42/ch6A/subchXIX/pt2/subpta/sec300aa-16.html.
  • 7[7]National Vaccine Injury Compensation Program Sec.300aa-15.Compensation[S/OL].[2006-12-15].http://www.washingtonwatchdog.gorg/documents/usc/ttl42/ch6A/subchXIX/pt2/subpta/sec300aa-15.html.
  • 8[8]Statistics Reports[EB/OL].[2006-12-15].http://www.hrsa.gov/vaccinecompensation/statistics_report.html.
  • 9[9]Strategic Plan[EB/OL].[2006-12-15].http://www.hrsa.gov/vaccinecompensation/strategic_plan.htm
  • 10Zhou WG.Surveillance for Safety After Immunization:Vaccine Adverse Event Reporting System(VAERS)--United States,1991-2001 [J].Surveillance Summaries,2003,52:SS-1

共引文献30

同被引文献67

引证文献8

二级引证文献43

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部